RES inhibits the interleukin‐6 (IL‐6)‐induced transcriptional activity of STAT3 in human prostate cancer LNCaP‐FGC cells18 and STAT3 axis in primary glioblastoma tumor‐initiating cells.19 Here, STAT3 is linked to Familial prostate cancer.